Visalytics
Visalytics
approved EB-2 (NIW)

Research Assistant III

Molecular Biology · Nigeria · 2025-10-31

Processing Time
347 days
Decision Date
2025-10-31
Location
Illinois
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research into developing novel treatment strategies for glioblastoma in older adults with diabetes. Her work focuses on the insulin pathway and drug interactions to identify therapeutic targets and improve survival outcomes for patients with aggressive brain cancer. She utilizes an interdisciplinary approach integrating molecular biology, biochemistry, and pathology.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses urgent medical challenges in glioblastoma treatment for the aging U.S. population.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., NIH-funded work, and 15 peer-reviewed publications demonstrate her readiness to lead this research.

3 Balance of Interests Met

The humanitarian and scientific value of improving cancer survival rates outweighs the need for labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in Anatomy and her record of 15 peer-reviewed journal articles which garnered 31 citations. Her work is supported by funding from the National Institutes of Health (NIH) and was validated by expert testimony confirming her contributions to understanding how nutrition impacts brain health. These factors satisfied all three prongs of the Dhanasar framework.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Original Contributions
Government Alignment

Similar Cases

Research Assistant

Research and Development · Mexico

WeGreened EB-2 (NIW) approved
2 days 2023-09-13
The petitioner proposes to investigate neuro-oncological conditions, specifically glioblastoma, to optimize treatments and develop novel therapies. The work focuses on identifying reliable diagnostic markers for neurodegenerative diseases such as Parkinson’s, Alzheimer’s, and mixed dementia. The goal is to enable earlier diagnosis and improve patient outcomes for the millions of Americans suffering from these conditions.
View Case

Research Scientist

Biotechnology · Russia

WeGreened EB-2 (NIW) approved
California 669 days 2025-12-04
The petitioner proposes to study how changes in RNA splicing facilitate the growth, spread, and recurrence of glioblastoma brain tumors. He aims to develop small drug-like molecules designed to block these harmful RNA changes to improve treatment efficacy for patients. This work focuses on creating practical therapeutic tools to combat aggressive brain cancers.
View Case

Postdoctoral Researcher

Research and Development · Pakistan

WeGreened EB-2 (NIW) approved
Massachusetts 4 days 2024-01-12
The petitioner proposes to develop mechanistic and statistical models to understand how cell-signaling and neural mechanisms contribute to the onset and maintenance of obesity, diabetes, and heart disease. This research aims to enhance healthcare capabilities and reduce the costs of disease by providing insights for managing and preventing chronic conditions.
View Case

Data Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
603 days 2025-09-20
The petitioner proposes to develop computational and analytical tools to characterize the mechanisms of chronic and complex diseases. This work involves integrating large-scale biological data to accelerate the discovery of treatment strategies for neurodegenerative disorders and metabolic diseases.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Nigeria

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-10-31.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 347 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Nigeria All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist